The findings from these bioinformatic studies may guide for mechanistical investigations and uncover potential therapeutic opportunities as we have demonstrated in this study with the discovery of mutually exclusive mutations targeting DNMT3A and CBFB-MYH11 fusion in AML. This evidence concerns the gene DNMT3A and acute myeloid leukemia.